E-mail:gzliang@cqu.edu.cn    Tel: (86)2365102507

Bioactive Peptide Statistics
Sequence characteristics of all bioactive peptides
The percentage of each amino acid coded at two terminals of different functional peptides
Peptide N-terminal (%) C-terminal (%)
Q N G S T H D E R A C M K V L P F Y I W Q N G S T H D E R A C M K V L P F Y I W
ACE-i 2.3 2.42 7.86 2.84 3.63 3.02 2.9 4.23 4.59 7.5 0.42 3.2 4.66 10.22 12.76 5.93 5.5 6.65 6.95 2.42 5.26 2.12 5.02 2.06 2.6 2.54 1.39 3.02 7.13 4.41 0.48 1.45 8.4 4.35 7.68 20.98 7.01 8.4 1.63 4.05
Renin-i 5.0 2.5 2.5 10.0 2.5 5.0 0.0 7.5 10.0 2.5 0.0 5.0 2.5 2.5 12.5 7.5 7.5 2.5 5.0 7.5 2.5 5.0 5.0 2.5 0.0 5.0 5.0 0.0 17.5 7.5 0.0 0.0 10.0 2.5 12.5 5.0 12.5 7.5 0.0 0.0
Vasorelaxation 25.0 0.0 25.0 0.0 0.0 0.0 0.0 0.0 25.0 0.0 0.0 0.0 0.0 0.0 0.0 25.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.0 0.0 0.0 50.0 0.0 0.0 25.0 0.0 0.0 0.0
Antihypertensive 1.1 1.92 7.14 3.85 3.85 1.92 1.92 1.92 7.42 6.32 0.27 4.4 4.67 9.62 11.81 5.49 4.67 8.79 10.71 2.2 3.85 2.2 4.4 1.1 2.2 1.92 1.65 3.3 4.67 3.85 0.55 0.55 5.77 4.4 8.24 21.98 8.52 11.81 0.82 8.24
Vasoconstriction 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.0 0.0 0.0 25.0 0.0 0.0 0.0 0.0 0.0 0.0 50.0 0.0 0.0 25.0 0.0 0.0 0.0 0.0 0.0 0.0 25.0 0.0 0.0 0.0 0.0 0.0 25.0 0.0 0.0 25.0 0.0 0.0 0.0
Antioxidative 3.67 2.48 6.05 4.96 3.47 4.07 3.97 4.46 3.37 7.54 1.49 2.98 4.07 8.53 11.61 5.16 5.06 8.13 4.66 4.27 5.46 3.57 3.37 3.27 3.47 3.87 2.98 5.26 6.25 6.35 1.29 2.48 9.52 3.67 11.31 7.64 5.65 7.94 2.78 3.87
Antimicrobial 6.36 1.32 24.12 4.39 1.75 0.88 2.63 1.54 10.31 6.8 2.41 1.75 5.26 7.68 5.92 1.54 9.21 3.29 2.19 0.66 3.06 1.09 19.91 3.72 0.44 1.09 1.09 1.53 12.69 5.03 14.66 0.44 6.56 2.41 13.13 2.41 3.06 2.84 1.31 3.5
Anticancer 0.83 3.33 25.0 1.67 0.83 0.83 1.67 4.17 5.0 4.17 1.67 3.33 12.5 4.17 8.33 1.67 9.17 2.5 5.83 3.33 5.0 0.83 7.5 4.17 2.5 0.83 2.5 4.17 6.67 1.67 4.17 0.83 15.83 4.17 11.67 4.17 8.33 5.0 5.83 4.17
Antithrombotic 2.98 3.57 13.1 4.17 5.95 5.36 5.95 5.36 7.14 6.55 2.38 2.98 7.14 4.76 6.55 3.57 4.17 2.38 5.36 0.6 3.57 1.79 4.17 2.38 2.38 0.6 1.19 5.36 20.83 4.76 1.79 0.6 23.21 5.36 2.98 7.74 6.55 3.57 1.19 0.0
Antiviral 7.69 0.0 0.0 0.0 0.0 0.0 0.0 7.69 0.0 7.69 0.0 0.0 0.0 0.0 69.23 0.0 0.0 0.0 7.69 0.0 0.0 0.0 7.69 15.38 0.0 0.0 0.0 15.38 0.0 0.0 0.0 0.0 15.38 0.0 23.08 0.0 0.0 7.69 15.38 0.0
DPP IV-i 2.08 0.83 8.75 2.08 5.0 1.25 1.25 4.17 2.5 6.67 0.83 3.75 2.5 10.83 16.25 5.0 5.42 5.0 10.0 5.83 5.83 1.25 5.83 1.25 2.92 1.25 1.67 4.17 4.58 11.25 0.0 2.92 6.67 4.58 15.83 15.42 4.58 5.42 2.92 1.67
α-Amylase-i 4.88 4.88 2.44 4.88 2.44 2.44 7.32 4.88 9.76 14.63 0.0 2.44 2.44 0.0 4.88 21.95 7.32 2.44 0.0 0.0 0.0 4.88 0.0 2.44 0.0 4.88 4.88 0.0 7.32 2.44 4.88 9.76 2.44 0.0 9.76 19.51 14.63 7.32 0.0 4.88
α-Glucosidase-i 4.26 2.13 0.0 4.26 2.13 2.13 6.38 4.26 6.38 8.51 2.13 6.38 10.64 6.38 10.64 6.38 2.13 14.89 0.0 0.0 2.13 6.38 2.13 2.13 0.0 2.13 6.38 4.26 10.64 6.38 0.0 8.51 2.13 0.0 10.64 2.13 17.02 6.38 2.13 8.51
Immunomodulatory 2.94 2.94 4.9 2.94 6.86 0.98 1.96 4.9 11.76 3.92 0.0 1.96 4.9 9.8 6.86 6.86 5.88 6.86 7.84 4.9 2.94 1.96 4.9 0.0 5.88 0.0 0.98 2.94 14.71 0.0 0.98 2.94 9.8 5.88 6.86 10.78 9.8 12.75 3.92 1.96
Opioid 0.0 0.0 5.31 2.65 2.65 0.0 0.0 0.88 4.42 0.88 0.0 0.0 0.88 4.42 4.42 1.77 4.42 66.37 0.0 0.88 5.31 5.31 6.19 1.77 6.19 0.0 0.88 4.42 7.08 5.31 0.0 0.88 2.65 2.65 10.62 12.39 8.85 15.04 2.65 1.77
PEP-i 1.89 0.94 1.89 3.77 1.89 4.72 0.0 5.66 7.55 5.66 0.94 5.66 1.89 11.32 9.43 14.15 3.77 3.77 15.09 0.0 1.89 2.83 0.94 1.89 1.89 2.83 0.0 2.83 2.83 8.49 0.0 0.0 0.94 9.43 2.83 30.19 1.89 8.49 12.26 7.55
Hypocholesterolemic 0.0 0.0 12.5 4.17 0.0 0.0 0.0 0.0 8.33 4.17 0.0 0.0 0.0 16.67 20.83 4.17 0.0 8.33 16.67 4.17 0.0 12.5 0.0 0.0 0.0 4.17 4.17 4.17 12.5 16.67 0.0 0.0 16.67 4.17 4.17 16.67 0.0 4.17 0.0 0.0
Mineral-binding 4.55 9.09 4.55 9.09 0.0 4.55 18.18 4.55 13.64 0.0 0.0 4.55 9.09 9.09 4.55 0.0 4.55 0.0 0.0 0.0 9.09 4.55 0.0 0.0 4.55 4.55 0.0 9.09 4.55 9.09 0.0 4.55 31.82 4.55 4.55 0.0 0.0 9.09 0.0 0.0
Heparin-binding 0.0 5.56 0.0 0.0 0.0 0.0 0.0 5.56 0.0 19.44 0.0 0.0 0.0 0.0 0.0 8.33 38.89 0.0 0.0 22.22 0.0 0.0 0.0 0.0 19.44 5.56 0.0 0.0 0.0 61.11 0.0 0.0 0.0 0.0 0.0 0.0 8.33 0.0 0.0 5.56
Neuropeptide 0.0 7.35 14.71 7.35 2.94 4.41 8.82 4.41 10.29 13.24 1.47 0.0 1.47 4.41 8.82 4.41 2.94 1.47 1.47 0.0 1.47 1.47 1.47 0.0 10.29 0.0 0.0 1.47 2.94 1.47 0.0 0.0 0.0 1.47 10.29 0.0 55.88 1.47 1.47 8.82
Regulating 0.0 0.0 44.44 0.0 11.11 0.0 11.11 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.33 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.11 0.0 0.0 0.0 0.0 0.0 11.11 0.0 22.22 44.44 0.0 11.11
Stimulating 0.0 0.0 4.55 9.09 4.55 0.0 0.0 9.09 4.55 4.55 4.55 0.0 4.55 13.64 18.18 4.55 0.0 4.55 13.64 0.0 9.09 0.0 9.09 4.55 9.09 4.55 0.0 18.18 0.0 0.0 0.0 0.0 0.0 9.09 22.73 4.55 0.0 0.0 9.09 0.0
Ileum contracting 0.0 0.0 10.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 10.0 0.0 0.0 0.0 20.0 0.0 40.0 0.0 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 100.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Celiac disease 39.76 0.0 1.2 1.2 0.0 0.4 0.0 0.8 0.4 1.61 0.0 0.0 0.0 6.83 5.62 32.13 4.02 2.81 2.01 1.2 39.36 2.41 0.4 2.01 2.41 1.2 0.0 1.61 1.61 2.01 0.0 0.4 0.0 2.41 5.62 8.03 15.26 8.03 6.02 1.2
Cytotoxic 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.29 0.0 0.0 14.29 14.29 14.29 0.0 0.0 0.0 14.29 28.57 0.0 0.0 0.0 0.0 0.0 0.0 28.57 0.0 0.0 0.0 0.0 0.0 0.0 14.29 42.86 0.0 14.29 0.0 0.0 0.0
Haemolytic 0.0 0.0 3.85 7.69 0.0 0.0 0.0 0.0 7.69 0.0 0.0 0.0 0.0 11.54 7.69 0.0 61.54 0.0 0.0 0.0 0.0 0.0 38.46 0.0 3.85 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.08 0.0 23.08 11.54 0.0 0.0
Anxiolytic-like 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.75 0.0 6.25 6.25 6.25 0.0 43.75 6.25 0.0 6.25 0.0 12.5 0.0 12.5 6.25 0.0 0.0 31.25 0.0 0.0 0.0 0.0 6.25 6.25 0.0 0.0 12.5 0.0 6.25
γ-Glutamyl 0.0 0.0 0.0 0.0 0.0 0.0 0.0 100.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.88 0.0 11.76 0.0 5.88 5.88 5.88 5.88 0.0 5.88 5.88 5.88 5.88 5.88 5.88 0.0 5.88 5.88 5.88 5.88
Blood-brain barrier 0.0 0.0 0.0 0.0 0.0 33.33 0.0 8.33 16.67 0.0 16.67 0.0 0.0 0.0 0.0 8.33 0.0 16.67 0.0 0.0 0.0 0.0 33.33 8.33 0.0 0.0 0.0 0.0 8.33 0.0 0.0 0.0 8.33 0.0 25.0 0.0 8.33 8.33 0.0 0.0
Other bioactivity 0.0 0.0 6.67 0.0 0.0 0.0 0.0 13.33 13.33 0.0 0.0 0.0 20.0 13.33 0.0 6.67 0.0 0.0 20.0 6.67 0.0 0.0 6.67 0.0 0.0 0.0 0.0 6.67 20.0 0.0 0.0 0.0 0.0 13.33 6.67 0.0 20.0 0.0 0.0 26.67
Multifunctional 1.45 1.71 8.04 2.9 2.77 2.37 1.84 3.69 6.46 6.59 0.26 3.82 3.82 9.88 11.59 5.8 4.61 10.54 7.91 3.95 4.87 1.98 4.87 1.84 2.11 1.58 1.58 2.77 5.93 5.01 0.66 1.98 9.49 4.08 10.41 16.34 8.43 9.49 2.11 4.48
percentage >= 10%;
7 <= percentage < 10%;
percentage < 7%;
The percentage of amino acid composition encoding different functional peptides
Peptide Amino acid
Q N G S T H D E R A C M K V L P F Y I W
ACE-i 4.53 2.88 7.59 3.95 3.57 2.76 2.63 4.26 4.32 6.71 0.76 1.88 4.99 7.83 9.35 14.88 4.88 5.64 4.7 1.88
Renin-i 2.98 4.76 3.57 5.36 1.19 2.38 6.55 6.55 8.33 3.57 1.19 1.79 4.17 4.17 12.5 6.55 13.69 2.98 4.17 3.57
Vasorelaxation 5.88 11.76 5.88 0.0 0.0 5.88 5.88 0.0 5.88 17.65 5.88 0.0 0.0 11.76 0.0 17.65 5.88 0.0 0.0 0.0
Antihypertensive 3.91 3.32 7.14 4.58 4.22 1.84 2.25 4.45 4.18 5.03 0.63 2.07 4.99 7.64 8.63 15.63 5.12 6.38 5.57 2.43
Vasoconstriction 7.14 0.0 0.0 0.0 7.14 0.0 3.57 7.14 0.0 0.0 10.71 0.0 3.57 10.71 0.0 21.43 14.29 10.71 0.0 3.57
Antioxidative 4.97 3.58 8.57 5.27 3.47 3.63 4.75 6.31 3.82 7.56 1.18 2.15 4.73 6.29 9.32 9.87 3.98 5.14 3.36 2.05
Antimicrobial 3.2 3.21 10.71 5.67 3.53 2.4 2.1 1.87 9.63 6.36 7.84 0.98 8.36 5.25 7.7 6.78 4.52 2.86 5.09 1.93
Anticancer 2.28 3.06 9.24 5.18 2.0 1.67 2.95 3.67 4.62 9.74 1.34 1.5 13.98 6.18 12.31 4.73 5.62 1.17 6.07 2.67
Antithrombotic 5.43 4.6 6.91 6.2 4.03 2.05 6.52 11.57 5.37 7.48 1.15 1.66 6.14 4.86 6.59 8.89 3.39 1.98 4.6 0.58
Antiviral 2.17 1.09 4.35 5.43 2.17 1.09 3.26 13.04 3.26 1.09 6.52 0.0 8.7 3.26 22.83 4.35 0.0 10.87 5.43 1.09
DPP IV-i 4.81 1.63 7.92 2.81 3.92 1.41 3.03 4.22 3.33 7.99 0.74 2.0 3.55 7.18 12.14 19.25 3.4 3.33 5.11 2.22
α-Amylase-i 3.04 4.97 7.46 4.14 1.38 3.59 3.04 2.76 3.04 10.77 4.14 4.97 1.38 4.42 13.26 15.75 6.08 2.21 2.21 1.38
α-Glucosidase-i 5.33 4.27 6.67 5.87 2.67 2.4 3.2 2.67 3.73 11.2 1.6 5.33 4.53 4.53 10.4 11.2 5.87 3.73 3.47 1.33
Immunomodulatory 5.5 3.4 5.5 5.63 6.28 1.18 3.01 5.76 6.54 3.14 0.79 2.36 8.25 6.81 7.46 10.99 5.24 4.58 6.28 1.31
Opioid 2.69 2.43 10.76 4.61 4.23 0.64 0.13 1.54 4.87 2.56 0.77 0.9 1.79 4.99 6.53 17.93 8.83 18.82 2.82 2.18
PEP-i 2.75 2.29 3.21 3.21 3.67 3.55 1.72 4.81 2.29 4.47 0.11 1.15 1.95 7.22 8.02 29.32 5.84 4.47 7.56 2.41
Hypocholesterolemic 2.98 6.55 5.95 2.38 2.98 1.19 4.17 8.33 2.98 8.33 1.19 1.19 4.76 13.69 7.74 12.5 0.6 3.57 7.14 1.79
Mineral-binding 6.82 4.04 3.03 15.4 4.29 2.02 3.28 16.16 2.02 4.55 0.76 3.54 7.32 5.3 3.28 5.81 0.51 3.54 7.83 0.51
Heparin-binding 5.44 1.59 5.22 2.49 2.49 0.45 0.0 0.45 10.2 22.0 6.8 4.54 10.88 2.04 4.99 2.49 4.54 0.0 0.91 12.47
Neuropeptide 1.68 8.12 6.28 5.67 2.91 2.45 2.76 2.91 13.02 5.51 0.31 1.53 2.76 3.52 12.56 6.43 11.79 3.22 3.22 3.37
Regulating 0.0 0.0 17.86 3.57 3.57 0.0 3.57 0.0 3.57 0.0 0.0 0.0 3.57 0.0 28.57 0.0 14.29 17.86 0.0 3.57
Stimulating 19.44 2.78 3.7 8.33 2.78 0.93 0.0 8.33 1.85 5.56 0.93 0.0 1.85 7.41 11.11 15.74 1.85 2.78 4.63 0.0
Ileum contracting 1.3 0.0 5.19 5.19 0.0 1.3 0.0 0.0 14.29 5.19 0.0 5.19 3.9 2.6 15.58 20.78 0.0 14.29 2.6 2.6
Celiac disease 39.68 1.11 2.06 3.78 1.11 0.84 0.24 1.62 1.18 0.98 0.47 0.3 0.24 2.73 4.75 26.16 7.18 3.07 2.16 0.34
Cytotoxic 0.0 5.8 10.14 2.9 4.35 0.0 2.9 1.45 14.49 4.35 7.25 1.45 5.8 8.7 11.59 2.9 2.9 0.0 7.25 5.8
Haemolytic 4.15 0.0 11.35 4.59 1.97 3.93 0.0 0.0 3.06 7.64 0.0 0.66 12.01 3.49 18.34 6.33 9.61 3.71 7.42 1.75
Anxiolytic-like 3.03 0.0 4.55 3.03 4.55 3.03 0.0 3.03 9.09 0.0 0.0 4.55 1.52 3.03 22.73 13.64 0.0 19.7 3.03 1.52
γ-Glutamyl 2.86 0.0 5.71 0.0 2.86 2.86 2.86 51.43 0.0 2.86 2.86 2.86 2.86 5.71 2.86 0.0 2.86 2.86 2.86 2.86
Blood-brain barrier 3.43 3.86 6.87 9.01 3.86 2.15 4.29 3.86 11.59 6.01 1.72 1.72 7.3 3.43 8.58 6.01 3.43 9.01 3.43 0.43
Other bioactivity 7.81 3.13 6.25 1.56 1.56 3.13 3.13 14.06 9.38 0.0 0.0 0.0 7.81 9.38 6.25 7.81 4.69 0.0 6.25 7.81
Multifunctional 4.22 2.83 6.99 4.39 3.02 2.25 2.12 4.45 4.56 6.76 1.14 2.04 5.62 7.37 10.11 13.63 5.01 6.28 4.83 2.37
percentage >= 10%;
7 <= percentage < 10%;
percentage < 7%;
Copyright © 2020. Record / license number: Chongqing ICP No. 2000214